Assessing and adjusting for differences between HIV prevalence estimates derived from national population-based surveys and antenatal care surveillance, with applications for Spectrum 2013 by Marsh, Kimberly et al.
 
Assessing and adjusting for differences between HIV prevalence
estimates derived from national population-based surveys and antenatal
care surveillance, with applications for Spectrum 2013
 
 
(Article begins on next page)
The Harvard community has made this article openly available.
Please share how this access benefits you. Your story matters.
Citation Marsh, Kimberly, Mary Mahy, Joshua A. Salomon, and Daniel R.
Hogan. 2014. “Assessing and adjusting for differences between HIV
prevalence estimates derived from national population-based surveys
and antenatal care surveillance, with applications for Spectrum 2013.”
AIDS (London, England) 28 (4): S497-S505.
doi:10.1097/QAD.0000000000000453.
http://dx.doi.org/10.1097/QAD.0000000000000453.
Published Version doi:10.1097/QAD.0000000000000453
Accessed February 17, 2015 7:55:26 AM EST
Citable Link http://nrs.harvard.edu/urn-3:HUL.InstRepos:13581101
Terms of Use This article was downloaded from Harvard University's DASH
repository, and is made available under the terms and conditions
applicable to Other Posted Material, as set forth at
http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-
use#LAAAssessing and adjusting for differences between HIV
prevalence estimates derived from national
population-based surveys and antenatal care
surveillance, with applications for Spectrum 2013
Kimberly Marsh
a, Mary Mahy
a, Joshua A. Salomon
b and
Daniel R. Hogan
c
Objective(s): To assess differences between HIV prevalence estimates derived from
national population surveys and antenatal care (ANC) surveillance sites and to improve
the calibration of ANC-derived estimates in Spectrum 2013 to more appropriately
account for differences between these data.
Design: Retrospective analysis of national population survey and ANC surveillance
data from 25 countries with generalized epidemics in sub-Saharan Africa and 8
countries with concentrated epidemics.
Methods: Adult national population survey and ANC surveillance HIV prevalence
estimateswere compared for all available national population survey data points for the
years 1999–2012. For sub-Saharan Africa, a mixed-effects linear regression model
determined whether the relationship between national population and ANC estimates
was constant across surveys. A new calibration method was developed to incorporate
national population survey data directly into the likelihood for HIV prevalence in
countries with generalized epidemics. Results were used to develop default rules for
adjusting ANC data for countries with no national population surveys.
Results: ANCsurveillancedatatypicallyoverestimatepopulationprevalence,although
a wide variation, particularly in rural areas, is observed across countries and survey
years. The new calibration method yields similar point estimates to previous
approaches, but leads to an average 44% increase in the width of 95% uncertainty
intervals.
Conclusion: ImportantbiasesremaininANCsurveillancedataforHIVprevalence.The
new approach to model-ﬁtting in Spectrum 2013 more appropriately accounts for this
bias when producing national estimates in countries with generalized epidemics. In
countrieswithconcentratedepidemics,localsexratiosshouldbeusedtocalibrateANC
surveillance estimates.  2014 Wolters Kluwer Health | Lippincott Williams & Wilkins
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Introduction
Nearly all countries conduct some form of HIV
surveillance to monitor patterns and trends in the HIV
epidemic [1]. In countries with generalized HIV
epidemics where HIV infection is ﬁrmly established in
the heterosexual population, sentinel surveillance among
pregnant women attending antenatal care (ANC) clinics
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each site, is the predominant data source for monitoring
the epidemic [2]. In countries with concentrated
epidemics where transmission of HIV occurs primarily
within high-risk groups such as injection drug users and
men who have sex with men, ANC surveillance data play
a smaller but still important role in determining whether
the epidemic has spread into the general population [3].
Despite the historical contributions of ANC surveillance,
theaccuracyofnationalHIVprevalenceestimatesderived
from these data has been an ongoing concern. The extent
to which ANC surveillance data represent the general
population prevalence depends on the combined effect of
a number of potential biases. First, prevalence among
pregnant women attending ANC clinics may not be
representative of pregnant women generally if ANC
uptake is low [2]. Second, ANC prevalence may not
reﬂect prevalence among the female population generally,
due either to selection for women at higher risk at
younger age or to the impact of HIV-related fertility
reductions among those who are older [4,5]. Finally,
ANC prevalence may not mirror national prevalence
because sentinel surveillance sites are not selected
randomly, and geographic coverage of lower-prevalence
rural areas may be limited [6,7]. The magnitude and
direction of these biases also may shift over time due to
changes in ANC uptake and fertility patterns among
women, as well as changes in participating sites [8–12].
National population-based household surveys, such as
Demographic and Health Surveys (DHS) and AIDS
Indicator Surveys (AIS), which incorporate HIV testing,
are increasingly used to improve accuracy in estimates of
national HIV prevalence levels [13]. Compared to ANC
surveillance, these surveys have broad geographic
representation and test both men and women [14].
Whereas national population surveys are considered the
gold standard for measuring HIV prevalence levels in the
general population, particularly in generalized epidemics,
the substantial technical and ﬁnancial resources they
require can limit their usefulness for monitoring trends
[13]. For many countries, intervals between surveys can
stretch to ﬁve or more years, and for countries with
concentrated epidemics, national population surveys are
not recommended as population prevalence is too low to
justify the effort and expense required to conduct them
[3]. ANC surveillance, on the contrary, is less costly and
simpler to conduct, which facilitates more frequent
measurement in any setting [2].
Most countries with generalized epidemics rely on a
combination of ANC surveillance and national popu-
lation survey data to produce national HIV prevalence
estimates using Spectrum, a modelling tool supported by
the Joint United Nations Programme on HIV/AIDS
(UNAIDS) [15–17]. Since 2007, Spectrum has been
implemented as part of a two-stage ﬁtting process, which
ﬁrst estimates prevalence trends based on ANC surveil-
lance data and then applies a post-ﬁtting calibration
approach that adjusts these prevalence trend estimates to
match prevalence levels estimated from national popu-
lation surveys [18]. For countries with generalized
epidemics, but no national population survey, UNAIDS
hasrecommendedadefault20%downwardadjustmentto
ANC-basedestimates inurbanand rural areasbased on an
analysisbyGouwsetal. [19]from26countrieswith ANC
and population survey data between 2001 and 2007. For
countries with concentrated epidemics, which histori-
cally divide low-risk population estimates by sex,
UNAIDS recommended a downward adjustment of
40% for women and 60% for men, based on an
unpublished comparison of ANC surveillance and
population survey data through 2007 from six countries
(report available from corresponding author).
Given the unique contributions that data from both
national population surveys and ANC surveillance can
make in informing national HIVestimates, it is critical to
understand how these estimates differ currently, whether
these differences have changed over time, and how
Spectrumcanbestincorporatebothdatasourcestoobtain
accurate estimates and projections of national HIV
epidemics. In this study, we provide an updated
comparison of adult HIV prevalence estimates from
national population surveys and ANC surveillance data
through 2012. For countries with generalized epidemics,
we explore if this relationship has changed over time. We
then describe a new, more parsimonious calibration
method within Spectrum that allows national population
survey data to more directly contribute to national
estimates.Finally,weprovidedefaultvaluesforcalibrating
Spectrum models for countries without national
population surveys.
Methods
Spectrum model overview
Spectrum employs a ‘susceptible-infected’ dynamic
model of HIV transmission to estimate trends in HIV
incidence, prevalence and AIDS mortality [15–17]. The
model is typically ﬁt to HIV prevalence data from
participating ANC surveillance sites. In the previous
versions of Spectrum, after ﬁtting the model, estimated
epidemic trajectories were calibrated to match HIV
prevalence levels observed in national population surveys
when available or calibrated downward based on default
values [18].
Spectrum currently offers three different modelling
options for how the force of infection parameter, r,i s
modelled within the dynamic transmission model: EPP
classic, r-spline, and r-trend. EPP classic relies on four
parameters to generate values for r [16], with relatively
S498 AIDS 2014, Vol 28 (Suppl 4)little ﬂexibility in patterns for r after the peak in
prevalence. This option may be less appropriate in recent
years for countries in sub-Saharan Africa (SSA), but it
provides a reasonable epidemic curve for those countries
with concentrated epidemics where the start of the
epidemic is more recent and data are sparse. R-spline uses
Bayesian penalized B-splines to generate smooth, ﬂexible
curves for r [20,21], which improves the model’s ability to
capture more complex epidemic patterns. R-trend also
generates ﬂexible curves for r, but does so by modelling r
as a linear combination of past prevalence, the past
infection rate, and a stabilization condition [22]. Brown
[17] described the current model implementations in
another article in this supplement.
Empirical comparison of national population
survey and antenatal care surveillance HIV
prevalence
AnalyseswererestrictedtoSSAcountrieswithgeneralized
epidemics that estimated urban and rural areas separately
and countries with concentrated epidemics that estimated
male and female low-risk populations separately. This
includes most countries that report to UNAIDS. For the
purposes of this analysis, countryepidemicswere classiﬁed
as generalized if national estimates of HIV prevalence
among adults aged 15–49 years were greater than 1%,
apart from Sa ˜o Tome ´ and Prı ´ncipe, which at the time of
analysis, classiﬁed its epidemic as concentrated.
We extracted national population survey HIV prevalence
estimates from the Spectrum 2012 ﬁles submitted by
countries to UNAIDS in July 2013. For most countries,
these national population estimates are also available
through online published DHS and AIS reports
(accessible at http://dhsprogram.com/Data/). Spectrum
Version 4.68 was used to construct national HIV
prevalence estimates based on ANC surveillance data
from the Spectrum 2012 ﬁles, except in Cambodia,
Vietnam and India. For these countries, we abstracted
mediannationalANCsurveillanceestimatesfor thesurvey
year from country reports [23–25] as India produces state
and union territory-level Spectrum ﬁles only, whereas
Vietnam and Cambodia use another UNAIDS-supported
modelling tool to produce estimates. For the six states in
India with population survey estimates, HIV prevalence
estimates were constructed using ANC surveillance data
from the Spectrum 2012 individual stateﬁles. In Vietnam,
the median ANC estimate was from the same province as
the population survey.
In countries with generalized epidemics, we used the
r-spline option to ﬁt the national prevalence curves based
on ANC data alone, except in rural Ghana, where the
r-trend option was used as it provided the only realistic
ﬁt. In concentrated epidemics, including the six states in
India, trends were ﬁt as speciﬁed by the country
depending on the availability of data and the start year
of the epidemic.
We calculated ratios of national population survey to
ANC surveillance HIV prevalence estimates for each
country and the national population survey year. In
generalized epidemics, ratios were stratiﬁed by urban and
rural areas. In concentrated epidemics, trends were ﬁt as
speciﬁed by the country depending on the availability of
data and the start year of the epidemic. Because ANC
prevalence data are typically analysed under the assump-
tionthattheyaredistributedapproximatelynormallyafter
transforming the data through a probit function, we
accounted for variance in population survey and ANC
dataacrosscountriesusingprobitdifferences,calculatedas
follows:
Probitdifference ¼ F 1ðPÞNP   F 1ðPÞANC: (1)
where P is the national population (NP) survey or ANC
surveillance prevalence and F 1 is the inverse of the
cumulative standard normal distribution. To detect
changes in the relationship between estimates from these
two data sources over time in countries with generalized
epidemics and more than one survey, we constructed a
multi-level longitudinal linear regression model of probit
differences, allowing for differences in slope and intercept
for regions and countries. Finally, to assess whether ANC
surveillance data could be adjusted to reﬂect national
population surveys, we applied the median regional ratios
in countries with generalized epidemics and the overall
median ratio in countrieswith concentrated epidemics to a
country’s ANC-based prevalence estimates. We then com-
pared this adjusted estimate to the corresponding national
population prevalence estimate. Analyses were conducted
in Stata version 12.
Spectrum calibration
The original approach to calibrating the Spectrum
model to match population-based survey prevalence
estimates involved re-sampling prevalence curves after
ﬁtting the model to the ANC prevalence data [18]. The
likelihood for ANC prevalence data (W)a s s u m e s
normally distributed random errors for clinics on the
probit scale:
Wst ¼ F 1ðrtÞþbs þ est (2)
where s denotes an ANC site, t denotes year, bs is the site-
speciﬁc random effect and the error term, and est
approximates the binomial variation [26].
The steps of the original calibration algorithm are as
follows:
(1) Fit the model using the probit-space random-effects
likelihood for ANC sites via incremental mixture
importance sampling.
(2) After ﬁtting, calculate the calibration constant, c,a s
the difference between the median ﬁtted modelled
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of HIV prevalence.
(3) Add c to each prevalence trajectory (on the probit scale).
(4) Re-sample these scaled trajectories with weights
proportional to a likelihood deﬁned as a probit-space
normal distribution for population survey prevalence
point estimates and standard errors.
This approach succeeded in adjusting Spectrum preva-
lence curves ﬁt to ANC data to match the national
estimates. However, it has a few limitations: trends in
survey data do not inﬂuence the initial model ﬁt, which is
increasingly important now that countries have multiple
surveys; it assumes the calibration constant, c, is known
with certainty, thus resulting in an underestimation of
uncertainty around the calibrated prevalence trajectories;
there-sampling step couldresult in a poorly characterized
posterior distribution if only a limited number of unique
posterior draws were re-sampled; and appropriately re-
scaled HIV incidence (as opposed to prevalence) curves
are not produced directly from the calibration process.
To address these limitations, a new calibration approach
was developed and implemented in Spectrum 2013 that
involves estimating the calibration constant as part of the
model-ﬁtting procedure. To do this, the likelihood is
expanded and the calibration constant, c, is estimated
along with other model parameters. As before, a probit
space, random-effects likelihood is used for the ANC
data, but a parameter for the calibration constant, c,i s
also estimated and a second equation is added for the
population survey data as follows:
ANCsurveillance : Wst ¼ F 1ðrtÞþc þ bs þ eanc
st
NPsurvey : Wst ¼ F 1ðrtÞþe
np
t
(3)
A diffuse prior for c is assumed to be distributed normally
[c   N(0.15,1)].
Although this approach can be used with any of the three
options for modelling r within Spectrum, the method-
ology was developed using the r-spline model and
implemented in R software [21], with later testing using
the r-trend model [22]. HIV prevalence estimates from
national population surveys and ANC surveillance time
series data were obtained from UNAIDS for sub-regions
of 20 countries with generalized epidemics: Burundi,
Burkina Faso, Cameroun, Congo, Co ˆte d’Ivoire,
Democratic Republic of Congo, Ethiopia, Ghana, Haiti,
Kenya, Lesotho, Malawi, Mali, Rwanda, Sierra Leone,
Swaziland, Tanzania, Uganda, Zambia, and Zimbabwe.
Data were used for development purposes and will not
necessarily match ofﬁcial UNAIDS estimates.
Calibration for countries with generalized
epidemics and no national population surveys
For countries with generalized epidemics but no national
population surveys, we also developed an updated
approach to calibrating prevalence curves derived from
the ANC data in Spectrum 2013. As before [18],
Spectrum is ﬁt to ANC data, and then a calibration
constant is added to each curve in the probit space.
However, to better represent the larger degree of
uncertainty in expected bias for ANC-based estimates
for countries without a population survey, a distinct value
for c is drawn for each re-sampled posterior draw of
prevalence during calibration. Values for c are drawn from
a normal distribution, which is parameterized with the
regional median probit difference calculated in the
empirical analysis described above, and a standard
deviation (SD) calculated from the regional posterior
distributions for c as estimated in Eq. (3).
Results
Empirical comparison of national population
survey and antenatal care surveillance HIV
prevalence
We identiﬁed59 surveys from 34countriesbetween 1987
and 2012 that reported urban and rural or sex-speciﬁc
HIV prevalence estimates. Of these, 49 were conducted
in 25 countries with generalized epidemics. Only ﬁve
countries in SSA (Angola, Eritrea, Gambia, Namibia and
Togo) had not conducted or published data from a
population survey at the time of this study. However,
Eritrea subsequently released a report on a 2010 national
population survey in August 2013, leaving only four
countries in SSA without a national population survey.
In countrieswith generalized epidemics, the relationships
between population survey and ﬁtted median ANC
surveillance estimates were highly variable across regions
(Fig. 1a–c).For themost part, however, ANCprevalence
overestimatedpopulationprevalence.Inthreeurbanareas
– Democratic Republic of Congo, 2007; Mali, 2006 and
Sierra Leone, 2005 – and six rural areas – Burundi, 1998,
2002, and 2010; Ethiopia, 2005; DRC, 2007; Liberia,
2007; Mali, 2006; and Sierra Leone, 2008 – ANC
prevalence was more than two times greater than
population prevalence (Supplemental Table 1, http://
links.lww.com/QAD/A575).Attheoppositeextreme,in
urban areas of Chad in 2005 and in rural areas of Co ˆte
d’Ivoire in 2012, ANC prevalence was just half that of the
populationprevalence.ComparisonofANCandnational
population survey trends across countries found no
change in the slope of probit differences in urban areas
over time [coefﬁcient of annual change: 0.001, 95%
conﬁdence interval (CI)  0.0123, 0.015). In rural areas,
an increasingly larger divergence between ANC surveil-
lance and population survey estimates over time was
identiﬁed (coefﬁcient of annual change: 0.015, 95% CI
0.003, 0.027). The largest changes in the magnitude of
bias across survey periods were observed for Burundi,
Co ˆte d’Ivoire, Ethiopia, Guinea and Kenya.
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Fig. 1. Ratio of adult HIV prevalence from national population surveys to prevalence derived from antenatal clinic surveillance
data for the year in which the survey was conducted for (a) Southern Africa, (b) Eastern Africa and (c) Western and Central
Africa. ANC, antenatal care sentinel surveillance HIV prevalence estimates; NP, national population survey HIV prevalence
estimates; SD, standard deviation.Similar to countries with generalized epidemics, ANC
surveillance estimates more often overestimated popu-
lation prevalence in concentrated epidemics, with
similarly large variations in the magnitude of bias
observed (Fig. 2). Despite this tendency, the most
extreme bias in ANC estimates was observed in Mexico
in 2002, 2006 and 2012, with a 4–10-fold excess in
prevalence among men compared to pregnant women
(Supplemental Table 2, http://links.lww.com/QAD/
A575). Data from ANC surveillance also underestimated
female population prevalence in Mexico in 2000 and
2012, and Sa ˜o Tome ´ and Prı ´ncipe in 2012, and male
populationprevalenceinManipur,Indiain2006,Mexico
in 2000, 2006 and 2012, Sa ˜o Tome ´ and Prı ´ncipe in 2009
and Vietnam in 2005.
Table 1 summarizes median ratios and probit differences
from population survey and ANC prevalence compari-
sons in generalized and concentrated epidemics. In
countries with generalized epidemics, overall and region-
speciﬁc values are presented alongside SDs derived using
the new calibration approach (results described in the
following section). In countries with generalized
epidemics, median bias in ANC surveillance data was
greater in rural than urban areas (a 32 versus 19%
overestimate, respectively). However, these results
masked substantial regional variation, with larger biases
across Western and Central Africa (30% overestimate in
urban areas and 41% overestimate in rural areas). When
the median regional values were used to adjust ANC
prevalence estimates for countries with national popu-
lation surveys, the adjusted ANC and national population
surveyestimateswere similar (SupplementalFig. 1a and b,
http://links.lww.com/QAD/A575). In countries with
concentrated epidemics, comparisons of population
survey prevalence to ANC surveillance by sex showed
a greater difference in women (53% downward
reduction) as compared to men (44% downward
reduction), although agreement between population
survey data and the adjusted ANC data was poor, and
especially so for men (Supplemental Fig. 2a and b, http://
links.lww.com/QAD/A575).
S502 AIDS 2014, Vol 28 (Suppl 4)
0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0 6.5 7.0 7.5 8.0 8.5 9.0 9.5 10.0 10.5 11.0 11.5 12.0
HIV prevalence ratio (NP: ANC)
Vietnam (Hai Phong) (2005)
c
Senegal (2011)
Senegal (2005)
Niger (2006)
Niger (2002)
Mexico (2012)
Mexico (2006)
Mexico (2000)
Mexico (1987)
Uttar Pradesh (2006)
Tamil Nadu (2006)
Maharastra (2006)
Manipur (2006)
Karnataka (2006)
Andhra Pradesh (2006)
India (2005-2006)
b
Diminican Republic (2007)
Diminican Republic (2002)
Cambodia(2002)
a
Male 
Female
São Tomé and Príncipe (2009)
Fig. 2. Ratio of population-based adult HIV prevalence from national population surveys to prevalence derived from antenatal
clinicdatafortheyearinwhichthesurveywasconductedinconcentratedepidemics.
aMedianANCsurveillanceestimateforthe
survey year in Cambodia was abstracted from [23].
bMedian ANC surveillance estimate for India (national) was abstracted from
[25].
cSex-speciﬁc estimates were not available forthe 2012 DHS in Niger.
dMedian ANC surveillance estimate for the survey year
in Vietnam was extracted from [24]. ANC, antenatal care; NP, national population; SD, standard deviation.
Table 1. Median ratios and probit differences of population survey (national population) and antenatal care surveillance HIV prevalence
estimates for urban and rural areas in countries with generalized epidemics and for women and men in concentrated epidemics.
Data source/region
NP:ANC median ratio Median probit difference Probit difference SD
Urban Rural Urban Rural Urban Rural
Countries with generalized epidemics 0.81 0.68  0.11  0.17 0.14 0.22
Eastern Africa 1.02 0.94 0.01  0.03 0.14 0.24
Southern Africa 0.84 0.94  0.14  0.04 0.10 0.07
Western/Central Africa 0.70 0.59  0.17  0.24 0.13 0.22
Women Men Women Men Women Men
Countries with concentrated epidemics 0.47 0.56  0.27  0.22 NA NA
ANC, antenatal care sentinel surveillance HIV prevalence estimate; NP, national population survey HIV prevalence estimate.Performance of the new calibration approach
The new calibration approach in Spectrum that directly
incorporates national population survey data into the
likelihood for HIV prevalence performed well for the 42
sub-national epidemics where it was tested. Point
estimates for prevalence obtained from the new, as
compared to the old, calibration method were similar for
the r-spline implementation (average root mean square
error across countries¼0.003) between 1995 and 2012.
Point estimates for c were also similar, with a correlation
of 0.99. The new calibration approach resulted in greater
uncertainty intervals around prevalence curves, with an
average increase in the width of 95% uncertainty intervals
of44%(seeexamplefor ruralCongoinFig.3a).Theonly
epidemicwithasubstantiallydifferentﬁtbetweenthetwo
calibration approaches was for rural Kenya, for which
three national population survey estimates were included
in model ﬁtting (Fig. 3b). Subsequent testing using the
r-trend model yielded similar median estimates for the
calibration constant as compared to those obtained with
r-spline (correlation 0.98).
Discussion
Results from this analysis provide evidence for an
ongoing bias in population prevalence estimates based
on ANC surveillance data, which may also be increasing
over time in rural areas for countries with generalized
epidemics. The largest bias was observed in countries in
Western and Central Africa, where median ANC-ﬁtted
prevalence was 30% higher in urban areas and 41% higher
in rural areas as compared to population survey estimates.
Estimates from countries in Eastern Africa, and to some
extent Southern Africa, had smaller differences. These
results also suggest that the single urban and rural
downward adjustment of 20% recommended in the past
versions of Spectrum might have either over-adjusted or
under-adjusted prevalence levels for the ﬁve countries
without national population surveys, depending on the
region. To better adjust for these biases in future versions
of Spectrum for those countries with generalized
epidemics that have not yet conducted a national
population survey, the updated median regional probit
differences as summarized in Table 1 have been
incorporated into the new approach for calibrating
models ﬁt to ANC data in Spectrum 2013.
For countries with generalized epidemics and population
survey data, our results show that the new approach to
calibrating ANC surveillance data to prevalence estimates
in Spectrum works well. In the majorityof cases, the new
calibration approach generated similar prevalence point
estimates as compared to the previous method. The fact
that this new approach had little impact on national
estimates is not surprising given that most countries had
only one or two national population surveys and the
expanded likelihood used in the new approach is
essentially a more parsimonious implementation of the
likelihoods used in the previous two-step calibration
procedure. This new approach also should improve the
model’sfuturecapabilitytohandlecountrieswiththreeor
more national population surveys.
The main implication of the new calibration approach is
that uncertainty intervals for national prevalence esti-
mates in Spectrum will be larger than previously
calculated for countries with and without surveys. This
is appropriate, as the previous approach assumed the
average difference between ANC and population survey
Population and antenatal care HIV prevalence differences Marsh et al. S503
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Fig. 3. Illustrative examples of point estimates and 95% uncertainty intervals for HIV prevalence curves calibrated to national
population-based survey prevalence estimates using old or new calibration method. (a) Rural Congo; (b) rural Kenya. Large solid
diamonds represent national population-based survey estimates for HIV prevalence. Smaller symbols denote HIV prevalence
estimates from ANC surveillance sites. ANC, antenatal care.prevalence estimates was known with certainty. By
estimating the calibration constant as part of the model-
ﬁtting process, the uncertainty around bias in ANC
prevalence estimates is now reﬂected in the uncertainty
intervals. This approach is also advantageous in that it
yields an appropriately calibrated posterior distribution
for all model parameters, and therefore all model output,
such as incidence and antiretroviral therapy (ART)
coverage. The primary limitation of this new approach,
however, is that it leads to longer ﬁtting times; typically
about 30% more likelihoods must be calculated to reach
model convergence.
A more general limitation of approaches thus far used to
calibrateestimatesinSpectrumisthatthemodelsassumea
constant relationship between ANC and population
prevalence over time. From empirical analyses presented
here for rural areas, this assumption may not be correct.
Possible reasons why trends in national population survey
and ANC prevalence estimates could differ include:
changing fertility patterns among young women [12,27],
the scale-up of prevention programmes, including
condom and other barrier contraception methods [4],
changes in the distribution of new, and most importantly,
prevalent HIV infections by age as the epidemic evolves
[9], and increasingly important, the impact of dramatic
scale-up of ART and prevention of mother-to-child
transmission programmes, which can inﬂuence the
fertility of the HIV-infected women [28–30]. Eaton et
al. [31] further reinforce the need to reconsider this
assumption within Spectrum. Results from their analysis
of DHS data from 13 countries in SSA show an average
18% (95% CI  9 to 38%) steeper decline in prevalence
among currently pregnant women as compared to all
women for surveys conducted over two time periods:
2003–2008 and 2009–2012 [31]. Adjusting for age
differences between the currently pregnant women and
non-pregnant women did not reduce the decline
substantially, suggesting other factors such as changes in
fertility patterns, particularly due to ART, will be
increasingly important to consider when interpreting
national HIV prevalence trends based on ANC surveil-
lance data.
TemporalchangesinselectionbiasarenotlimitedtoANC
surveillance data alone, however, and it is possible that
national population estimates may be differentially biased
over survey periods, especially if participation is con-
ditioned on HIV status. Although a study by Mishra et al.
[32] using national population survey data from 14
countries suggested that the effect of non-participation
biasonpopulationestimateswaslikelytobeminimal,more
recent analyses using Heckmen-type selection models
suggest that these biases may be considerably larger than
previously estimated [33,34]. As the number of surveys
increase within countries, calibration to an average value
across all national population surveyestimates may need to
be reconsidered in future versions of Spectrum.
Whereas the relationship between national population
survey and ANC surveillance estimates can be reasonably
described for countries in SSA and the methods for
calibrating ANC surveillance data are considered fairly
robust, the same cannot be said for countries with
concentrated epidemics. On the basis of national
population surveys available through 2012, and in
contrast with the previous study of surveys available
through 2007, we found that the bias in ANC data to be
larger when compared to women (53% overestimate) as
compared to men (44% overestimate). With regard to the
robustness of these ﬁndings, however, we found only
moderate agreement between adjusted ANC and
population prevalence for women and poor agreement
between ANC estimates and population prevalence for
men.Inconsistency intherelationship betweenANCand
population prevalence by sex across the six states in India
also suggest that local dynamics of the epidemic within a
country may be important to take into account. As a
result, we recommend that countries with concentrated
epidemics and no population surveys use local sex ratios
to inform calibration of ANC surveillance estimates
whenever feasible.
In conclusion, we found that important biases remain in
ANC surveillance data for HIV prevalence, and we
developed a more parsimonious approach to adjust
Spectrum projections to match national estimates of HIV
prevalence from population-based surveys. However, we
also found that differences between ANC and popu-
lation-based surveys may not be constant across time,
suggesting additional research at the individual country
level is needed to better understand these dynamics and
how to account for them in Spectrum. The expanded
likelihood implemented here suggests that additional
sources of nationally representative information on HIV
epidemics also could be incorporated into future versions
of Spectrum to help improve the accuracy of its
projections. In particular, data on HIV incidence or
mortality could be included as additional likelihood
components, providing a more comprehensive set of
calibration targets than the current reliance on HIV
prevalence estimates alone.
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